Nippon India Pharma Fund vs UTI Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8459 Cr | ₹1126 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.82 | 2.22 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -2.24% | -1.99% |
| 6 Month | -0.03% | 0.48% |
| 1 Year | -1.23% | -2.09% |
| 3 Year | 21.3% | 23.72% |
| 5 Year | 15.18% | 14.88% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | -0.82% | -1.84% |
| 1 Year | 4.97% | 5.72% |
| 3 Year | 16.4% | 19.68% |
| 5 Year | 16.13% | 17.73% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 16.62% | 11.64% |
| 3 Year | 20.93% | 16.55% |
| 5 Year | 20.36% | 14.82% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.36% | 14.3% |
| Sharp | 0.98% | 1.08% |
| Beta | 0.87% | 0.89% |
| Alpha | 1.45% | 3.32% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Funds Managed | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.34 | 5.77 |
| Mid Cap | 35.32 | 34.95 |
| Small Cap | 30.74 | 38.55 |
| Large Cap | 32.6 | 20.74 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 0.55 | 1.25 |
| Healthcare | 99.45 | 97.71 |
| Basic Materials | - | 1.03 |
Top Comparisons
BANDHAN Flexi Cap Fund - Regular Plan - Growth
3Y Returns15.25%
Canara Robeco Flexicap Fund - Regular Plan - Growth Option
3Y Returns14.81%
Mirae Asset Banking and PSU Fund Regular Growth Plan
3Y Returns7.01%
Sundaram Banking and PSU Fund - Regular Plan - Growth
3Y Returns7.42%
Aditya Birla Sun Life Short Term Fund - Growth - Regular Plan
3Y Returns7.47%
LIC MF Short Term Debt Fund Regular - Growth
3Y Returns6.86%
Aditya Birla Sun Life Corporate Bond Fund - Growth - Regular Plan
3Y Returns7.66%
Axis Corporate Bond Fund - Regular Plan Growth
3Y Returns7.53%